This enhancement introduces a configurable Weight Cap for eligible weight-based drugs, allowing practices to define a maximum weight used for dosage calculations. When a patient's recorded weight exceeds the configured threshold, the system automatically applies the capped weight during dose calculations and displays visual indicators throughout oncology workflows to identify capped dosing.
This enhancement introduces a redesigned Drug Forecasting Report that provides a more comprehensive view of upcoming medication requirements for oncology practices. The report includes enhanced forecasting, advanced filtering, patient-level details, improved NDC management, alternative drug selection, and expanded print and export capabilities to support inventory planning and reduce medication waste.
This enhancement significantly expands the Clinical Trials Research Module by providing a centralized workspace for managing research data, trial documentation, sign-off workflows, and consolidated reporting. The updated module introduces new research sections, streamlined trial summary creation, enhanced report management, and improved collaboration for clinical research teams.
This enhancement introduces the Therapies Nearing Completion report within the Chemotherapy Manager Dashboard. The report enables practices to proactively identify patients whose chemotherapy therapies are approaching completion, helping providers review and extend treatment plans without relying on manual chart reviews.
This enhancement captures and displays plan/product type information from eligibility responses directly on the Charge page. Plan Type (EB04) and Plan Description (EB05) are now stored at the charge level for the applicable Date of Service (DOS), providing greater visibility into insurance plan details and reducing the need for manual review of eligibility responses.
This enhancement adds direct access to drug flagging functionality within the Treatment Flowsheet. Users can now apply drug-level flags without leaving the treatment workflow, improving efficiency when managing medications in the Chemotherapy Manager.
This enhancement allows users to change a Resolved Adverse Event back to Active status when additional follow-up, updates, or ongoing monitoring is required. The feature restores editability while preserving key event information and maintaining accurate adverse event tracking.
This enhancement introduces Severity of Pain as a standardized clinical data point across multiple oncology and patient care workflows. Users can now document, view, configure, report on, and incorporate patient pain assessments throughout vitals collection, administration workflows, flowsheets, provider notes, templates, and reports. These updates provide greater visibility into patient pain levels and support more comprehensive clinical documentation and monitoring.
This enhancement introduces a configurable Body Surface Area (BSA) cap for dosage calculations across oncology workflows. Practices can define a maximum BSA threshold through Practice Settings, allowing the system to automatically cap dosage calculations when a patient's calculated BSA exceeds the configured value. The enhancement also provides visibility into capped dosing throughout ordering, planning, administration, flowsheets, provider notes, alerts, and reports, ensuring consistent dosage calculations and transparency across clinical workflows.
This enhancement synchronizes total dose behavior for Custom and Trial Drugs with that of normal drugs in the Chemotherapy Manager. Providers can now override the system-calculated total dose for custom and trial drugs configured with unit-based dosing (e.g., mg/m²) directly within a draft chemotherapy plan. The total dose appears as a clickable hyperlink, enabling physicians to adjust the calculated value when clinically required, while the originally prescribed unit dose remains unchanged. All overrides are fully tracked in reports and audit logs, ensuring transparency and traceability.
Posted On: Jul 22, 2026
Posted On: Jul 21, 2026
Posted On: Jul 21, 2026
Posted On: Jul 14, 2026
Posted On: Jul 14, 2026
Posted On: Jul 14, 2026